Gene · 6314
Papers1,627
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,627
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A genome-wide approach for the discovery of novel repeat expansion disorders in the Undiagnosed Diseases Network cohort. | Genet Med | 2025 | 40417743 | PubTator, text mining | PubMed |
| Epidemiology of Autosomal Dominant Spinocerebellar Ataxias in Latin America: A Systematic Review and Meta-Analysis. | Cerebellum | 2025 | 40138010 | PubTator, text mining | PubMed |
| In Silico Analysis of miRNA-Regulated Pathways in Spinocerebellar Ataxia Type 7. | Curr Issues Mol Biol | 2025 | 40136424 | PubTator, text mining | PubMed |
| Retraction Note: Circular RNA ATXN7 promotes the development of gastric cancer through sponging miR-4319 and regulating ENTPD4. | Cancer Cell Int | 2025 | 40082959 | PubTator, text mining | PubMed |
| ATXN10 Gene Expansions in Mexican Patients with Ataxia Without Epilepsy. | Cerebellum | 2025 | 39820777 | PubTator, text mining | PubMed |
| Multi-omic insights into molecular mechanism and therapeutic targets in spinocerebellar ataxia type 7. | Mol Ther Nucleic Acids | 2025 | 39817193 | PubTator, text mining | PubMed |
| Substantia nigra degeneration in spinocerebellar ataxia 2 and 7 using neuromelanin-sensitive imaging. | Eur J Neurol | 2025 | 39757380 | PubTator, text mining | PubMed |
| YTHDC1-Mediated lncRNA MSC-AS1 m6A Modification Potentiates Laryngeal Squamous Cell Carcinoma Development via Repressing ATXN7 Transcription. | Mol Biotechnol | 2025 | 38637450 | PubTator, text mining | PubMed |
| Case Series of Cerebellar Ataxia with Tremor Due to Heterozygous STUB1 Variants (SCA48) without TBP Expansions: Further Evidence for SCA48 as a Monogenic Disease. | Cerebellum | 2024 | 39680235 | PubTator, text mining | PubMed |
| Increased nuclear import characterizes aberrant nucleocytoplasmic transport in neurons from patients with spinocerebellar ataxia type 7. | Front Mol Neurosci | 2024 | 39649105 | PubTator, text mining | PubMed |
| Rare Spinocerebellar Ataxia Types in Canada: A Case Series and Review of the Literature. | Can J Neurol Sci | 2024 | 39618416 | PubTator, text mining | PubMed |
| Screening for SCA27B, CANVAS and other repeat expansion disorders in Greek patients with late-onset cerebellar ataxia suggests a need to update current diagnostic algorithms. | J Neurol Sci | 2024 | 39571249 | PubTator, text mining | PubMed |
| Trivalent immunization with metal-binding proteins confers protection against enterococci in a mouse infection model. | FEMS Microbes | 2024 | 39524556 | PubTator, text mining | PubMed |
| Spinocerebellar Ataxia in Brazil: A Comprehensive Genotype - Phenotype Analysis. | Cerebellum | 2024 | 39317855 | PubTator, text mining | PubMed |
| Purkinje Cell Dendritic Swellings: A Postmortem Study of Essential Tremor and Other Cerebellar Degenerative Disorders. | Cerebellum | 2024 | 39230844 | PubTator, text mining | PubMed |
| The 5HT4R agonist velusetrag efficacy on neuropathic chronic intestinal pseudo-obstruction in PrP-SCA7-92Q transgenic mice. | Front Pharmacol | 2024 | 39139632 | PubTator, text mining | PubMed |
| Longitudinal Changes of Clinical, Imaging, and Fluid Biomarkers in Preataxic and Early Ataxic Spinocerebellar Ataxia Type 2 and 7 Carriers. | Neurology | 2024 | 39133883 | PubTator, text mining | PubMed |
| Analyses of the Mx family members in lumpfish: Molecular characterization, phylogeny, and gene expression analyses. | Dev Comp Immunol | 2024 | 38992732 | PubTator, text mining | PubMed |
| Tremor-associated short tandem repeat intermediate and pathogenic expansions in familial essential tremor. | Brain Commun | 2024 | 38961870 | PubTator, text mining | PubMed |
| Progressive degeneration in a new Drosophila model of spinocerebellar ataxia type 7. | Sci Rep | 2024 | 38906973 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6314/papers?page=3